BD EVP Mike Garrison retires after 20 years
He led Medical Essentials and BioPharma Systems segments, effective Oct 2.
See the latest news and media coverage for BD. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical technology company
bd.comLast updated
In short: BD reported strong fiscal 2026 second-quarter results, raised its full-year EPS guidance, and appointed Vitor Roque as permanent CFO.
He led Medical Essentials and BioPharma Systems segments, effective Oct 2.
The all-in-one central line insertion system simplifies procedures with fewer steps and enhances patient and clinician safety.
Roque, interim CFO since December 2025, has over 25 years at BD in senior finance roles. He advances the New BD strategy and financial performance.
Revenue reaches $4.7 billion, up 5.2% reported. Adjusted EPS is $2.90. Raises full-year adjusted EPS guidance. Executes $2.0 billion share repurchase.
July 31 () - Becton Dickinson said on Friday it is issuing a recall on certain lots of medical needle sets in the U. after...
BD Canada's head office building in Mississauga, On, Canada_ By JHVEPhoto Becton, Dickinson and...
Following this transaction, the insider now owns 21,084 shares of the company. Becton Dickinson & Co (BDX) is a global medical technology company that develops...
Becton (BDX) quarterly earnings analysis examines AI-driven demand, earnings forecasts, and technical momentum with institutional investor focus and future outlook. Becton Dickinson (BDX) reported ...
Track BD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BD and other trending companies.